Microsoft has unveiled plans to launch a biological computing platform called Station B. The system will use a computational model to simulate the interactions of millions of combinations of genetic and environmental factors, helping scientists to conduct research more efficiently and create beneficial new manufactured DNA sequences in living cells. Breech Odu works in an Oxford Biomedica lab, where the Station B platform will be deployed to accelerate discovery and manufacturing of gene and cell therapies. The project is being developed in collaboration with Princeton University and the UK-based companies Oxford Biomedica and Synthace. “Synthetic biology is an exciting field that promises to transform our understanding of life on Earth,” said Bill Gates, Microsoft’s co-founder and chairman emeritus.
Microsoft has unveiled plans to launch a biological computing platform called Station B. The system will use a computational model to simulate the interactions of millions of combinations of genetic and environmental factors, helping scientists to conduct research more efficiently and create beneficial new manufactured DNA sequences in living cells. The project is being developed in collaboration with Princeton University and the UK-based companies Oxford Biomedica and Synthace. “Synthetic biology is an exciting field that promises to transform our understanding of life on Earth,” said Bill Gates, Microsoft’s co-founder and chairman emeritus.